Screening performance of C-reactive protein for active pulmonary tuberculosis in HIV-positive patients: A systematic review with a meta-analysis

AD Meca, A Turcu-Stiolica, M Bogdan… - Frontiers in …, 2022 - frontiersin.org
Background Tuberculosis (TB) is the leading infectious cause of mortality worldwide. In the
last years, resistant strains of the etiological agent, Mycobacterium tuberculosis, have …

Ratios from full blood count as markers for TB diagnosis, treatment, prognosis: a systematic review

N Fritschi, N Vaezipour, M Buettcher… - … of Tuberculosis and …, 2023 - ingentaconnect.com
BACKGROUND: The monocyte-to-lymphocyte (MLR) and neutrophil-to-lymphocyte (NLR)
ratio are calculated from routine full blood counts. The aim of this study was to systematically …

Risk of death in comorbidity subgroups of hospitalized COVID-19 patients inferred by routine laboratory markers of systemic inflammation on admission: a …

R Cocoş, B Mahler, A Turcu-Stiolica, A Stoichiță… - Viruses, 2022 - mdpi.com
Our study objective was to construct models using 20 routine laboratory parameters on
admission to predict disease severity and mortality risk in a group of 254 hospitalized COVID …

High pretreatment level of neutrophil to lymphocyte ratio, monocyte to lymphocyte ratio and other factors associated with delayed sputum conversion in patients with …

K Suryana, NWW Dharmesti, IBN Rai - Infection and drug …, 2022 - Taylor & Francis
Introduction Patients with delayed intensive phase sputum conversion have a higher risk of
multidrug resistant-tuberculosis (MDR-TB) and poorer treatment outcomes. Both, host …

Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease

SW Pan, RR Syed, DG Catanzaro, ML Ho… - Frontiers in …, 2022 - frontiersin.org
Objectives Human mitochondrial cell-free DNA (Mt-cfDNA) may serve as a useful biomarker
for infectious processes. We investigated Mt-cfDNA dynamics in patients with pulmonary …

Hematological parameters in newly diagnosed TB patients: a systematic review and meta-analysis

M Farhadian, S Veisi, N Farhadian, MH Zamanian - Tuberculosis, 2024 - Elsevier
Despite all efforts, tuberculosis (TB) remains one of the 10 leading causes of death
worldwide. The hematopoietic system is seriously affected by TB and there is little …

Prediction of treatment outcome with inflammatory biomarkers after 2 months of therapy in pulmonary tuberculosis patients: Preliminary results

S Stefanescu, R Cocoș, A Turcu-Stiolica, ES Shelby… - Pathogens, 2021 - mdpi.com
Pro-inflammatory mediators play an important role in the pathogenesis of pulmonary
tuberculosis. Consecutively, 26 pulmonary tuberculosis patients were enrolled in our study …

[HTML][HTML] Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania—A Systematic Review

DD Vulcanescu, IC Bagiu, CR Avram, LA Oprisoni… - Antibiotics, 2024 - mdpi.com
Background: The COVID-19 pandemic has intensified concerns over bacterial infections and
antimicrobial resistance, particularly in Romania. This systematic review explores bacterial …

Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT. TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial …

Z Yu, Z Shang, Q Huang, F Wen, S Patil - Frontiers in Microbiology, 2024 - frontiersin.org
Background The clinical challenge of differentiating suspected tuberculosis with positive T-
SPOT. TB results persist. This study aims to investigate the utility of the Systemic Immune …

2D-DIGE based urinary proteomics and functional enrichment studies to reveal novel Mycobacterium tuberculosis and human protein biomarker candidates for …

A Kaushik, S Bandyopadhyay, C Porwal… - Biochemical and …, 2022 - Elsevier
In the absence of a sensitive and specific diagnostic modality capable of detecting all forms
of tuberculosis (TB), proteomics may identify specific Mycobacterium tuberculosis (M. tb) …